Review




Structured Review

Azenta sgrna target regions
Sgrna Target Regions, supplied by Azenta, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sgrna target regions/product/Azenta
Average 86 stars, based on 1 article reviews
sgrna target regions - by Bioz Stars, 2026-05
86/100 stars

Images



Similar Products

99
New England Biolabs cas9 sgrna target regions
Cas9 Sgrna Target Regions, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cas9 sgrna target regions/product/New England Biolabs
Average 99 stars, based on 1 article reviews
cas9 sgrna target regions - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

86
Azenta sgrna target regions
Sgrna Target Regions, supplied by Azenta, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sgrna target regions/product/Azenta
Average 86 stars, based on 1 article reviews
sgrna target regions - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

90
Synthego Inc sgrnas targeting genomic regions flanking rs1882961
Sgrnas Targeting Genomic Regions Flanking Rs1882961, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sgrnas targeting genomic regions flanking rs1882961/product/Synthego Inc
Average 90 stars, based on 1 article reviews
sgrnas targeting genomic regions flanking rs1882961 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Synthego Inc sgrnas targeting the 20–200 region at the 3’- and 5’- end of the snp rs1173771
Sgrnas Targeting The 20–200 Region At The 3’ And 5’ End Of The Snp Rs1173771, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sgrnas targeting the 20–200 region at the 3’- and 5’- end of the snp rs1173771/product/Synthego Inc
Average 90 stars, based on 1 article reviews
sgrnas targeting the 20–200 region at the 3’- and 5’- end of the snp rs1173771 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Synthego Inc sgrna targeting the junction of single snp rs1173771 region deletion site
Sgrna Targeting The Junction Of Single Snp Rs1173771 Region Deletion Site, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sgrna targeting the junction of single snp rs1173771 region deletion site/product/Synthego Inc
Average 90 stars, based on 1 article reviews
sgrna targeting the junction of single snp rs1173771 region deletion site - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

95
Addgene inc sgrnas targeting aavs1 control region
( A ) Volcano plot representing results of whole genome CRISPR/Cas9 screen performed in EKO OCI-AML1 cells during exposure to 1 μM of S656 compound ( n = 1, around 10 sgRNAs per gene). ( B ) Schematic representation of the Cullin4-RING E3 ubiquitin ligase (CRL4) complex. ( C ) Dose response experiment to determine IC 50 values of S656 in OCI-AML5 cells, in regular media or supplemented by 25 nM of the neddylation inhibitor MLN4924 to prevent CRL-mediated proteolysis. IC 50 values were determined after 4 days of incubation (mean +/− SD, n = 3, biological replicates, t test, P value = 0.0478). ( D ) Quantitative proteome-wide mass spectrometry analysis performed in OCI-AML5 cells exposed to 8 μM of S656 for 5 h (CCNK = cyclin K, n = 3, biological replicates). ( E ) Cyclin K degradation assessment by measuring the mean fluorescence intensity (MFI) of cyclin K eGFP over mCherry by flow cytometry. OCI-AML5 G7 clone was treated for 3 h with 10 μM of the indicated compounds. Results are normalized to fluorescence in DMSO-treated cells (mean +/− SD, n = 5, biological replicates, t test, P value < 0.0001). ( F ) Immunoblot analysis of cyclin K and CDK12 protein levels in OCI-AML5 cells, after exposure to increasing concentrations of HQ461 or S656 for 6 h. Tubulin is used as a loading control. ( G ) Immunoblot analysis of cyclin K protein levels after exposure to HQ461 or S656 (5 μM for 5 h). Where indicated, OCI-AML5 cells were pre-treated 1 h with 500 nM of MLN4924 or MG132. ( H ) Immunoblot analysis of DDB1 and cyclin K protein levels after exposure to S656 (5 μM for 5 h) in OCI-AML5 Cas9 cells expressing inducible ( + DOX) sgRNAs targeting DDB1 or control region <t>AAVS1</t> . ( I ) Dose response experiment to determine S656 IC 50 values in inducible ( + DOX) OCI-AML5 Cas9 cells expressing two different sgRNAs targeting DDB1 gene or AAVS1 control region (mean +/− SD, 4 days incubation, n = 3, biological replicates, t test, P value = 0.0006 and 0.0118 in sgDDB1 #1 and #2, respectively). See also Appendix Fig. S . .
Sgrnas Targeting Aavs1 Control Region, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sgrnas targeting aavs1 control region/product/Addgene inc
Average 95 stars, based on 1 article reviews
sgrnas targeting aavs1 control region - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

99
Qiagen sgrna target regions
( A ) Volcano plot representing results of whole genome CRISPR/Cas9 screen performed in EKO OCI-AML1 cells during exposure to 1 μM of S656 compound ( n = 1, around 10 sgRNAs per gene). ( B ) Schematic representation of the Cullin4-RING E3 ubiquitin ligase (CRL4) complex. ( C ) Dose response experiment to determine IC 50 values of S656 in OCI-AML5 cells, in regular media or supplemented by 25 nM of the neddylation inhibitor MLN4924 to prevent CRL-mediated proteolysis. IC 50 values were determined after 4 days of incubation (mean +/− SD, n = 3, biological replicates, t test, P value = 0.0478). ( D ) Quantitative proteome-wide mass spectrometry analysis performed in OCI-AML5 cells exposed to 8 μM of S656 for 5 h (CCNK = cyclin K, n = 3, biological replicates). ( E ) Cyclin K degradation assessment by measuring the mean fluorescence intensity (MFI) of cyclin K eGFP over mCherry by flow cytometry. OCI-AML5 G7 clone was treated for 3 h with 10 μM of the indicated compounds. Results are normalized to fluorescence in DMSO-treated cells (mean +/− SD, n = 5, biological replicates, t test, P value < 0.0001). ( F ) Immunoblot analysis of cyclin K and CDK12 protein levels in OCI-AML5 cells, after exposure to increasing concentrations of HQ461 or S656 for 6 h. Tubulin is used as a loading control. ( G ) Immunoblot analysis of cyclin K protein levels after exposure to HQ461 or S656 (5 μM for 5 h). Where indicated, OCI-AML5 cells were pre-treated 1 h with 500 nM of MLN4924 or MG132. ( H ) Immunoblot analysis of DDB1 and cyclin K protein levels after exposure to S656 (5 μM for 5 h) in OCI-AML5 Cas9 cells expressing inducible ( + DOX) sgRNAs targeting DDB1 or control region <t>AAVS1</t> . ( I ) Dose response experiment to determine S656 IC 50 values in inducible ( + DOX) OCI-AML5 Cas9 cells expressing two different sgRNAs targeting DDB1 gene or AAVS1 control region (mean +/− SD, 4 days incubation, n = 3, biological replicates, t test, P value = 0.0006 and 0.0118 in sgDDB1 #1 and #2, respectively). See also Appendix Fig. S . .
Sgrna Target Regions, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sgrna target regions/product/Qiagen
Average 99 stars, based on 1 article reviews
sgrna target regions - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

90
Beijing SyngenTech Co single-guide rnas (sgrnas) targeting enhancer regions around the foxf2 genomic locus
( A ) Volcano plot representing results of whole genome CRISPR/Cas9 screen performed in EKO OCI-AML1 cells during exposure to 1 μM of S656 compound ( n = 1, around 10 sgRNAs per gene). ( B ) Schematic representation of the Cullin4-RING E3 ubiquitin ligase (CRL4) complex. ( C ) Dose response experiment to determine IC 50 values of S656 in OCI-AML5 cells, in regular media or supplemented by 25 nM of the neddylation inhibitor MLN4924 to prevent CRL-mediated proteolysis. IC 50 values were determined after 4 days of incubation (mean +/− SD, n = 3, biological replicates, t test, P value = 0.0478). ( D ) Quantitative proteome-wide mass spectrometry analysis performed in OCI-AML5 cells exposed to 8 μM of S656 for 5 h (CCNK = cyclin K, n = 3, biological replicates). ( E ) Cyclin K degradation assessment by measuring the mean fluorescence intensity (MFI) of cyclin K eGFP over mCherry by flow cytometry. OCI-AML5 G7 clone was treated for 3 h with 10 μM of the indicated compounds. Results are normalized to fluorescence in DMSO-treated cells (mean +/− SD, n = 5, biological replicates, t test, P value < 0.0001). ( F ) Immunoblot analysis of cyclin K and CDK12 protein levels in OCI-AML5 cells, after exposure to increasing concentrations of HQ461 or S656 for 6 h. Tubulin is used as a loading control. ( G ) Immunoblot analysis of cyclin K protein levels after exposure to HQ461 or S656 (5 μM for 5 h). Where indicated, OCI-AML5 cells were pre-treated 1 h with 500 nM of MLN4924 or MG132. ( H ) Immunoblot analysis of DDB1 and cyclin K protein levels after exposure to S656 (5 μM for 5 h) in OCI-AML5 Cas9 cells expressing inducible ( + DOX) sgRNAs targeting DDB1 or control region <t>AAVS1</t> . ( I ) Dose response experiment to determine S656 IC 50 values in inducible ( + DOX) OCI-AML5 Cas9 cells expressing two different sgRNAs targeting DDB1 gene or AAVS1 control region (mean +/− SD, 4 days incubation, n = 3, biological replicates, t test, P value = 0.0006 and 0.0118 in sgDDB1 #1 and #2, respectively). See also Appendix Fig. S . .
Single Guide Rnas (Sgrnas) Targeting Enhancer Regions Around The Foxf2 Genomic Locus, supplied by Beijing SyngenTech Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/single-guide rnas (sgrnas) targeting enhancer regions around the foxf2 genomic locus/product/Beijing SyngenTech Co
Average 90 stars, based on 1 article reviews
single-guide rnas (sgrnas) targeting enhancer regions around the foxf2 genomic locus - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


( A ) Volcano plot representing results of whole genome CRISPR/Cas9 screen performed in EKO OCI-AML1 cells during exposure to 1 μM of S656 compound ( n = 1, around 10 sgRNAs per gene). ( B ) Schematic representation of the Cullin4-RING E3 ubiquitin ligase (CRL4) complex. ( C ) Dose response experiment to determine IC 50 values of S656 in OCI-AML5 cells, in regular media or supplemented by 25 nM of the neddylation inhibitor MLN4924 to prevent CRL-mediated proteolysis. IC 50 values were determined after 4 days of incubation (mean +/− SD, n = 3, biological replicates, t test, P value = 0.0478). ( D ) Quantitative proteome-wide mass spectrometry analysis performed in OCI-AML5 cells exposed to 8 μM of S656 for 5 h (CCNK = cyclin K, n = 3, biological replicates). ( E ) Cyclin K degradation assessment by measuring the mean fluorescence intensity (MFI) of cyclin K eGFP over mCherry by flow cytometry. OCI-AML5 G7 clone was treated for 3 h with 10 μM of the indicated compounds. Results are normalized to fluorescence in DMSO-treated cells (mean +/− SD, n = 5, biological replicates, t test, P value < 0.0001). ( F ) Immunoblot analysis of cyclin K and CDK12 protein levels in OCI-AML5 cells, after exposure to increasing concentrations of HQ461 or S656 for 6 h. Tubulin is used as a loading control. ( G ) Immunoblot analysis of cyclin K protein levels after exposure to HQ461 or S656 (5 μM for 5 h). Where indicated, OCI-AML5 cells were pre-treated 1 h with 500 nM of MLN4924 or MG132. ( H ) Immunoblot analysis of DDB1 and cyclin K protein levels after exposure to S656 (5 μM for 5 h) in OCI-AML5 Cas9 cells expressing inducible ( + DOX) sgRNAs targeting DDB1 or control region AAVS1 . ( I ) Dose response experiment to determine S656 IC 50 values in inducible ( + DOX) OCI-AML5 Cas9 cells expressing two different sgRNAs targeting DDB1 gene or AAVS1 control region (mean +/− SD, 4 days incubation, n = 3, biological replicates, t test, P value = 0.0006 and 0.0118 in sgDDB1 #1 and #2, respectively). See also Appendix Fig. S . .

Journal: EMBO Reports

Article Title: DDB1 engagement defines the selectivity of S656 analogs for cyclin K degradation over CDK inhibition

doi: 10.1038/s44319-025-00448-y

Figure Lengend Snippet: ( A ) Volcano plot representing results of whole genome CRISPR/Cas9 screen performed in EKO OCI-AML1 cells during exposure to 1 μM of S656 compound ( n = 1, around 10 sgRNAs per gene). ( B ) Schematic representation of the Cullin4-RING E3 ubiquitin ligase (CRL4) complex. ( C ) Dose response experiment to determine IC 50 values of S656 in OCI-AML5 cells, in regular media or supplemented by 25 nM of the neddylation inhibitor MLN4924 to prevent CRL-mediated proteolysis. IC 50 values were determined after 4 days of incubation (mean +/− SD, n = 3, biological replicates, t test, P value = 0.0478). ( D ) Quantitative proteome-wide mass spectrometry analysis performed in OCI-AML5 cells exposed to 8 μM of S656 for 5 h (CCNK = cyclin K, n = 3, biological replicates). ( E ) Cyclin K degradation assessment by measuring the mean fluorescence intensity (MFI) of cyclin K eGFP over mCherry by flow cytometry. OCI-AML5 G7 clone was treated for 3 h with 10 μM of the indicated compounds. Results are normalized to fluorescence in DMSO-treated cells (mean +/− SD, n = 5, biological replicates, t test, P value < 0.0001). ( F ) Immunoblot analysis of cyclin K and CDK12 protein levels in OCI-AML5 cells, after exposure to increasing concentrations of HQ461 or S656 for 6 h. Tubulin is used as a loading control. ( G ) Immunoblot analysis of cyclin K protein levels after exposure to HQ461 or S656 (5 μM for 5 h). Where indicated, OCI-AML5 cells were pre-treated 1 h with 500 nM of MLN4924 or MG132. ( H ) Immunoblot analysis of DDB1 and cyclin K protein levels after exposure to S656 (5 μM for 5 h) in OCI-AML5 Cas9 cells expressing inducible ( + DOX) sgRNAs targeting DDB1 or control region AAVS1 . ( I ) Dose response experiment to determine S656 IC 50 values in inducible ( + DOX) OCI-AML5 Cas9 cells expressing two different sgRNAs targeting DDB1 gene or AAVS1 control region (mean +/− SD, 4 days incubation, n = 3, biological replicates, t test, P value = 0.0006 and 0.0118 in sgDDB1 #1 and #2, respectively). See also Appendix Fig. S . .

Article Snippet: Clonal OCI-AML5 cells expressing an inducible Cas9 (Addgene plasmid #50661 (Wang et al, )) were generated and then infected with lentiviruses for constitutive expression of sgRNAs targeting AAVS1 control region (Addgene plasmid #50662 (Wang et al, )) or DDB1 #1 (GGAAAAGACCAACCTCCTGG); #2 (AAAGGCCATCATAGAGACGC).

Techniques: CRISPR, Ubiquitin Proteomics, Incubation, Mass Spectrometry, Fluorescence, Flow Cytometry, Western Blot, Control, Expressing